Efficacy of Surgicel Powder for prevention of hematoma after septoplasty. Randomized controlled trial.

Efficacy of Surgicel Powder for prevention of hematoma after septoplasty. Randomized controlled trial. - Investigation of the preventive effect of Surgicel Powder on nasal septal hematoma. Randomized controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049470

Enrollment

Registered

2023-03-01

Start date

2023-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasal septal disease

Interventions

Group applying Surgicel powder for mucous membrane fixation after nasal septum surgery Group of suture fixation of mucosa after nasal septum surgery with silicone plate Group of mucosa fixation after

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing nasal septal surgery

Exclusion criteria

Exclusion criteria: Anticoagulant medication

Design outcomes

Primary

Measure	Time frame
Presence of nasal septal hematoma Postoperative pain, bleeding Stress of postoperative procedures Evaluate from 1 day to 3 months postoperatively	—

Countries

Japan

Contacts

Public ContactYu Hosokawa

Saitama medical university hospital Otorhinolaryngology

hosokawa.yu@1972.saitama-med.ac.jp0492761111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026